Back to shop
Retatrutide (Reta) labelled vial
Weight Loss
Longevity
Cognitive

Retatrutide (Reta)

$115.00

per 20 mg vial

Retatrutide (Reta) is the "triple agonist": it targets GLP-1, GIP and glucagon receptors at once, one step beyond semaglutide and tirzepatide research. Key researched benefits: • Up to 24% average weight loss in a 48-week trial, among the largest results seen in this research class • Liver fat dropped by up to 86% in trial participants, with most reaching normal levels • Studied for less hunger, feeling full for longer and burning more stored fat for energy • Better blood sugar and insulin response seen in metabolic studies • Lower cholesterol, triglycerides and blood pressure reported in trial data • Growing research into heart health, brain health (including dementia risk) and healthy ageing Why researchers choose Reta: glucagon activity adds an energy-burning effect that GLP-1-only compounds do not have. 99%+ purity, independently lab tested, with batch COA reports on this page. For laboratory research use only. Not for human consumption. Published trial results do not guarantee individual outcomes.

Product code
RT20
Size
20 mg vial
Categories
Weight Loss · Longevity · Cognitive
Purity
99.393%
Form
Lyophilized powder
Storage
Reconstituted vials store at 2°C–8°C | New sealed vials 6+ months up to 2 yrs store in non-defrosting freezer
Availability
In stock

For research use only. Backed by manufacturer Certificates of Analysis, with independent third-party COAs published on-site where available.

Lab report 1 of 2 (COA) · Janoshik Analytical

Blind GLP-1 test submitted by Enhanced Health & Wellness Peptides. Manufacturer SN-M155Y, batch Clear Pink Caps. Results apply to the tested sample pulled directly from our active inventory batch (Batch ID: WP-SN-RT20.0926).

Retatrutide 20 mg certificate of analysis
Lab
Janoshik Analytical
Tested
Retatrutide 20 mg
Date
September 16, 2026
Purity
99.393%
Content
22.65 mg per vial
Task #
231916
Verify key
VX12DAC6XE68

Lab report 2 of 2 (COA) · Peptide Test Canada (Side-Chain Analytics)

HPLC-MS/MS group test, order PTC-489913, sample RET-934, batch Clear Pink Caps. Results apply to the tested sample pulled directly from our active inventory batch.

Retatrutide 20 mg certificate of analysis
Lab
Peptide Test Canada (Side-Chain Analytics)
Tested
Retatrutide 20 mg
Date
October 30, 2026
Purity
99.6%
Content
24.65 mg per vial (123.3% of label)
Task #
COA-2026-SC-04410
Verify key
PTC-4GV657F7

Customer reviews

No reviews yet
Read reviews & write a review

Discreet, protected delivery

Discreet packaging

Plain, unbranded packaging. No product names or logos on the outside.

Protected in transit

Each vial is individually cushioned to protect the powder from impact.

Canada Post tracking

Tracking number sent as soon as your package ships.

Reship guarantee

Confirmed lost in transit? We reship at no extra cost.

Storage & handling FAQ

Questions about testing, shipping or returns? Read our FAQ · New batch reports: Lab updates & Telegram